KU Leuven's autoimmune disease therapy developer Imcyse, which is targeting type 1 diabetes, has raised close to $39m in equity and debt financing in its latest effort.

University at Buffalo has spun out Surgino to tackle the risk of hernias following surgical stitching, with a tool intended to improve measurements of tension in the stitched tissues.

Chugai, Eisai, SoftBank, Takeda and Celgene have contributed to healthcare venture firm Catalys Pacific’s inaugural fund, which has a target size of $100m.

Goldman Sachs invested in AstraZeneca-founded Viela Bio's latest round, taking the 6 Dimensions Capital-backed biopharmaceutical developer's total funding to more than $300m.

Sector analysis: Healthcare

Winner of the CVC Investment in a Spinout of the Year: Ribon Therapeutics - Novartis Venture Fund, Johnson & Johnson Innovation–JJDC, Takeda Ventures, Celgene

The enterprise health plan software provider has now raised more than $430m in total, with SoftBank Vision Fund leading a round that also featured GV.

GlaxoSmithKline and Alphabet have exited the online drug delivery platform, which has been acquired by Allscripts in a deal reported to be less than $40m in size.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

University of Central Florida's Cytosen has been acquired in an all-stock deal by Kiadis Pharma, in a transaction potentially worth up to $70m.